{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Bimatoprost+Ophthalmic&page=4", "query": { "intervention": "Bimatoprost Ophthalmic", "page": 4 }, "page_size": 10 }, "pagination": { "page": 4, "page_size": 10, "total_count": 76, "total_pages": 8, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Bimatoprost+Ophthalmic&page=5&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Bimatoprost+Ophthalmic&page=3&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-05T18:28:44.788Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01525173", "title": "A Safety and Efficacy Study of ALPHAGAN® P and LUMIGAN® in Subjects Previously Treated With Latanoprost for Glaucoma and Ocular Hypertension", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Glaucoma", "Ocular Hypertension" ], "interventions": [ { "name": "0.1% brimonidine tartrate ophthalmic solution", "type": "DRUG" }, { "name": "0.01% bimatoprost ophthalmic solution", "type": "DRUG" }, { "name": "0.2% hypromellose lubricant eye drops", "type": "DRUG" }, { "name": "latanoprost 0.005% ophthalmic solution", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Allergan", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 137, "start_date": "2012-01", "completion_date": "2012-10", "has_results": true, "last_update_posted_date": "2013-12-04", "last_synced_at": "2026-10-05T18:28:44.788Z", "location_count": 1, "location_summary": "Deerfield Beach, Florida", "locations": [ { "city": "Deerfield Beach", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT01525173" }, { "nct_id": "NCT00355446", "title": "Bioavailability of Bimatoprost Ophthalmic Solution in Human Aqueous.", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Cataract" ], "interventions": [ { "name": "Bimatoprost 0.03%", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Indiana University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 48, "start_date": "2001-07", "completion_date": "2004-10", "has_results": false, "last_update_posted_date": "2007-10-17", "last_synced_at": "2026-10-05T18:28:44.788Z", "location_count": 4, "location_summary": "Indianapolis, Indiana", "locations": [ { "city": "Indianapolis", "state": "Indiana" }, { "city": "Indianapolis", "state": "Indiana" }, { "city": "Indianapolis", "state": "Indiana" }, { "city": "Indianapolis", "state": "Indiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT00355446" }, { "nct_id": "NCT01253902", "title": "Ocular Surface Tolerability Study of Prostaglandin Analogues in Patients With Open-Angle Glaucoma or Ocular Hypertension", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Glaucoma, Open-Angle", "Ocular Hypertension" ], "interventions": [ { "name": "bimatoprost ophthalmic solution 0.01%", "type": "DRUG" }, { "name": "travoprost ophthalmic solution 0.004%", "type": "DRUG" }, { "name": "latanoprost ophthalmic solution 0.005%", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Allergan", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 164, "start_date": "2010-12", "completion_date": "2011-10", "has_results": true, "last_update_posted_date": "2012-11-07", "last_synced_at": "2026-10-05T18:28:44.788Z", "location_count": 1, "location_summary": "Rogers, Arkansas", "locations": [ { "city": "Rogers", "state": "Arkansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01253902" }, { "nct_id": "NCT00705757", "title": "The Effects of Xalatan, Travatan and Lumigan on Skin Pigmentation Near the Eye", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Glaucoma", "Application Site Pigmentation Changes" ], "interventions": [ { "name": "latanoprost", "type": "DRUG" }, { "name": "bimatoprost", "type": "DRUG" }, { "name": "travoprost", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Summa Health System", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "30 Years", "maximum_age": null, "sex": "ALL", "summary": "30 Years and older" }, "enrollment_count": 89, "start_date": "2008-03", "completion_date": "2011-04", "has_results": true, "last_update_posted_date": "2016-01-18", "last_synced_at": "2026-10-05T18:28:44.788Z", "location_count": 2, "location_summary": "Arlington Heights, Illinois • Akron, Ohio", "locations": [ { "city": "Arlington Heights", "state": "Illinois" }, { "city": "Akron", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT00705757" }, { "nct_id": "NCT05729594", "title": "Systemic Pharmacokinetic Study of T4032 (Unpreserved Bimatoprost 0.01%) Eye Gel Versus Lumigan® 0.01% Eye Drops in 40 Healthy Volunteers", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy Volunteers" ], "interventions": [ { "name": "Bimatoprost Ophthalmic", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Laboratoires Thea", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 40, "start_date": "2023-02-27", "completion_date": "2023-04-05", "has_results": false, "last_update_posted_date": "2023-11-14", "last_synced_at": "2026-10-05T18:28:44.788Z", "location_count": 1, "location_summary": "Newark, New Jersey", "locations": [ { "city": "Newark", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT05729594" }, { "nct_id": "NCT02250651", "title": "Efficacy and Safety of Bimatoprost Sustained-Release (SR) in Patients With Open-Angle Glaucoma or Ocular Hypertension", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Glaucoma, Open-Angle", "Ocular Hypertension" ], "interventions": [ { "name": "Bimatoprost SR", "type": "DRUG" }, { "name": "Sham: Applicator Without Needle", "type": "OTHER" }, { "name": "Active Comparator: Timolol 0.5%", "type": "DRUG" }, { "name": "Timolol Vehicle (placebo)", "type": "DRUG" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Allergan", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 528, "start_date": "2014-12-15", "completion_date": "2020-07-22", "has_results": true, "last_update_posted_date": "2021-07-28", "last_synced_at": "2026-10-05T18:28:44.788Z", "location_count": 51, "location_summary": "Dothan, Alabama • Chandler, Arizona • Fayetteville, Arkansas + 47 more", "locations": [ { "city": "Dothan", "state": "Alabama" }, { "city": "Chandler", "state": "Arizona" }, { "city": "Fayetteville", "state": "Arkansas" }, { "city": "Glendora", "state": "California" }, { "city": "Hemet", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02250651" }, { "nct_id": "NCT00539526", "title": "Evaluation of Hyperemia With the Use of Ocular Prostaglandin Analogues", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Open Angle Glaucoma", "Ocular Hypertension" ], "interventions": [ { "name": "Bimatoprost 0.03%", "type": "DRUG" }, { "name": "travoprost 0.004%", "type": "DRUG" }, { "name": "latanoprost 0.005% eye drops", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Allergan", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 106, "start_date": "2007-09", "completion_date": "2008-09", "has_results": true, "last_update_posted_date": "2019-04-24", "last_synced_at": "2026-10-05T18:28:44.788Z", "location_count": 1, "location_summary": "San Diego, California", "locations": [ { "city": "San Diego", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00539526" }, { "nct_id": "NCT07217678", "title": "Biomarkers of Ocular Surface Damage in the Setting of Topical Ocular Hypotensive Medication Use", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Glaucoma", "Open-Angle Glaucoma", "Ocular Hypertension", "Glaucoma Suspect" ], "interventions": [ { "name": "Durysta, Bimatoprost Intracameral Implant 10 µg", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Miami", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 20, "start_date": "2026-02-09", "completion_date": "2028-01-31", "has_results": false, "last_update_posted_date": "2026-03-05", "last_synced_at": "2026-10-05T18:28:44.788Z", "location_count": 1, "location_summary": "Miami, Florida", "locations": [ { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT07217678" }, { "nct_id": "NCT00348023", "title": "Bimatoprost Monotherapy vs. Dual Therapy With Travoprost and Timolol in Patients With Glaucoma and Ocular Hypertension", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Glaucoma" ], "interventions": [ { "name": "Bimatoprost 0.03%, Travoprost 0.004%, Timolol 0.5%", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Innovative Medical", "sponsor_class": "INDUSTRY", "healthy_volunteers": null, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": null, "start_date": null, "completion_date": null, "has_results": false, "last_update_posted_date": "2007-02-09", "last_synced_at": "2026-10-05T18:28:44.788Z", "location_count": 1, "location_summary": "Pittsburgh, Pennsylvania", "locations": [ { "city": "Pittsburgh", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT00348023" }, { "nct_id": "NCT05401357", "title": "Bioequivalence Study With Clinical Endpoint Comparing Bimatoprost Ophthalmic Solution 0.01% and LUMIGAN® in the Treatment of Chronic Open-Angle Glaucoma or Ocular Hypertension in Both Eyes.", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Glaucoma, Open-Angle", "Ocular Hypertension" ], "interventions": [ { "name": "Test - Bimatoprost 0.01% Ophthalmic Solution", "type": "DRUG" }, { "name": "Reference - LUMIGAN® (Bimatoprost 0.01% Ophthalmic Solution)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Amneal Pharmaceuticals, LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 168, "start_date": "2022-06-29", "completion_date": "2022-12", "has_results": false, "last_update_posted_date": "2022-08-10", "last_synced_at": "2026-10-05T18:28:44.788Z", "location_count": 9, "location_summary": "Newport Beach, California • Petaluma, California • New Smyrna Beach, Florida + 6 more", "locations": [ { "city": "Newport Beach", "state": "California" }, { "city": "Petaluma", "state": "California" }, { "city": "New Smyrna Beach", "state": "Florida" }, { "city": "Morrow", "state": "Georgia" }, { "city": "Roswell", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT05401357" } ] }